Spotlight
A selection of resources from across the Federation
Resource
Advancing Sex Workers’ Sexual and Reproductive Health and Rights: A Toolkit for Inclusive Programming
This toolkit is grounded in international guidance and frameworks on sex workers’ health and human rights.
Most Popular This Week
Resource
|
Advancing Sex Workers’ Sexual and Reproductive Health and Rights: A Toolkit for Inclusive Programming
Sexual and reproductive health and rights (SRHR) are not only an integral part of the right to health but also necessary to enjoy many other human rights.
Resource
|
IPPF Annual Report and Financial Statements 2025
IPPF is a global federation and movement of 100+ locally led Member Associations and Collaborative Partnersin 150+ countries, dedicated to sexual and reproductive health, rights
Resource
|
Annual Performance Report 2025
The IPPF Annual Performance Report 2025 tells a story of resilience, solidarity and shared leadership across our Federation.
Resource
|
Review of IPPF’s Governance Reform
Following IPPF’s governance reform in 2019/2020, a review of the reform process was conducted, which provided important insights for the new Board of Trustees and the Secretariat to support the cha
Resource
|
IMAP Statement on Sex Worker-Centred Sexual and Reproductive Health Services
This statement is intended to provide guidance to Member Associations and Collaborative Partners across the Federation on delivering comprehensive, evidence‑based sexual and reproductive health (SR
Filter our resources by:
Resource
| 15 March 2018
Integration of DMPA‑SC into the method mix contributes to increased uptake of all methods of family planning
Injectable contraceptives are an increasingly popular method of family planning. They are safe, discrete, highly effective, and generally last for several months. Sayana® Press, also known as subcutaneous depot medroxyprogesterone (DMPA‑SC), is a lower‑dose formula version of the already popular injectable Depo‑Provera. DMPA‑SC combines the drug and needle in a single‑use unit, which makes it easy to transport and simple to use with little training. DMPA‑SC can be administered by community health workers (CHWs) and women themselves – potentially making injectable contraceptives available to women who can’t easily travel to clinics.
Resource
| 15 March 2018
Integration of DMPA‑SC into the method mix contributes to increased uptake of all methods of family planning
Injectable contraceptives are an increasingly popular method of family planning. They are safe, discrete, highly effective, and generally last for several months. Sayana® Press, also known as subcutaneous depot medroxyprogesterone (DMPA‑SC), is a lower‑dose formula version of the already popular injectable Depo‑Provera. DMPA‑SC combines the drug and needle in a single‑use unit, which makes it easy to transport and simple to use with little training. DMPA‑SC can be administered by community health workers (CHWs) and women themselves – potentially making injectable contraceptives available to women who can’t easily travel to clinics.
Resource
| 15 March 2018
Integration of DMPA‑SC into the method mix contributes to increased uptake of all methods of family planning
Injectable contraceptives are an increasingly popular method of family planning. They are safe, discrete, highly effective, and generally last for several months. Sayana® Press, also known as subcutaneous depot medroxyprogesterone (DMPA‑SC), is a lower‑dose formula version of the already popular injectable Depo‑Provera. DMPA‑SC combines the drug and needle in a single‑use unit, which makes it easy to transport and simple to use with little training. DMPA‑SC can be administered by community health workers (CHWs) and women themselves – potentially making injectable contraceptives available to women who can’t easily travel to clinics.
Resource
| 15 March 2018
Integration of DMPA‑SC into the method mix contributes to increased uptake of all methods of family planning
Injectable contraceptives are an increasingly popular method of family planning. They are safe, discrete, highly effective, and generally last for several months. Sayana® Press, also known as subcutaneous depot medroxyprogesterone (DMPA‑SC), is a lower‑dose formula version of the already popular injectable Depo‑Provera. DMPA‑SC combines the drug and needle in a single‑use unit, which makes it easy to transport and simple to use with little training. DMPA‑SC can be administered by community health workers (CHWs) and women themselves – potentially making injectable contraceptives available to women who can’t easily travel to clinics.
